Delivery Order SPE2DE24D0021-SPE2D625F0EKH
- Not listed
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $4,027.32 for 24 units of AFFIRM VPIII test kits under a fixed-price contract with economic price adjustment provisions. The award was made by the Medical Supply Chain, a defense-focused federal agency, on May 12, 2025, with an ultimate completion date of May 20, 2025. This delivery order represents a child contract with no set-aside designation, allowing Fisher Scientific to compete openly for the opportunity....
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $3,356.10 for 24 units of AFFIRM VPIII Test Kits under a fixed-price contract with economic price adjustment provisions. The contract was awarded on June 2, 2025, with an ultimate completion date of June 5, 2025, and will be performed in Pittsburgh, Pennsylvania. This delivery order represents a child contract with no set-aside designation, indicating open competition procurement. The funding agency is the Department of...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,342.44 for 24 units of AFFIRM VPIII Test Kits on July 24, 2025, with an ultimate completion date of July 29, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and will be performed in Pittsburgh, Pennsylvania. This award was issued without a set-aside designation, reflecting open competition. The funding source is the Medical Supply Chain, a defense-focused...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,684.88 on September 4, 2025, for 24 units of AFFIRM VPIII test kits to support the Medical Supply Chain, a defense-focused federal agency. This fixed-price contract with economic price adjustment provisions has an ultimate completion date of September 9, 2025, and will be performed in Pittsburgh, Pennsylvania. The contract was awarded through open competition with no set-aside designation, reflecting Fisher Scientific's...
- Fisher Scientific Company L.L.C. was awarded a delivery order on July 30, 2025, valued at $1,342.44 for the procurement of 24 units of AFFIRM VPIII test kits. The contract is a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of August 4, 2025. The award was made through the Defense or Civilian Medical Supply Chain funding agency with no set-aside designation, indicating open competition. Performance of this delivery order will take...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $10,068.30 for 24 units of AFFIRM VPIII test kits to support the Medical Supply Chain, a defense-focused federal agency. This fixed-price contract with economic price adjustment was awarded on September 11, 2025, with an ultimate completion date of September 16, 2025. The contract represents a child order under a larger vehicle and will be performed at Fisher Scientific's Pittsburgh, Pennsylvania location. As a major...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,342.44 on June 17, 2025, for the procurement of 24 units of AFFIRM VPIII test kits. This fixed-price contract with economic price adjustment has an ultimate completion date of June 23, 2025, and will be performed in Pittsburgh, Pennsylvania. The award was made without a set-aside designation, reflecting Fisher Scientific's competitive standing in federal procurement. The funding agency is the Defense Medical Supply Chain,...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,013.66 for 24 units of AFFIRM VPIII Test Kits under a fixed-price contract with economic price adjustment provisions. The contract was awarded on August 4, 2025, with an ultimate completion date of August 7, 2025, and will be performed in Pittsburgh, Pennsylvania. The award was made without a set-aside designation, reflecting open competition. The funding agency is the Medical Supply Chain, a defense-focused division...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $5,369.76 on August 20, 2025, for the procurement of 24 units of AFFIRM VPIII test kits. This fixed-price delivery order with economic price adjustment authority is scheduled for completion by August 28, 2025, and will be performed in Pittsburgh, Pennsylvania. The award was made without a set-aside designation, reflecting open competition procurement procedures. The funding agency is the Medical Supply Chain within the...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $5,369.76 on August 19, 2025, for 24 units of AFFIRM VPIII Test Kits to support the Medical Supply Chain, a defense-focused federal agency. The contract is classified as a child award under a fixed-price delivery order with economic price adjustment provisions, with an ultimate completion date of August 22, 2025. The order will be fulfilled and performed in Pittsburgh, Pennsylvania. No set-aside designation was used in...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F0EKHDelivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,013.66 for 24 units of AFFIRM VPIII Test Kits on August 5, 2025, with an ultimate completion date of August 8, 2025. This fixed-price contract with economic price adjustment was issued by the Medical Supply Chain, a defense-focused federal agency, with performance to take place in Pittsburgh, Pennsylvania. The award represents a child contract and was made without a set-aside designation, reflecting open competition procurement. As a major supplier of scientific products and laboratory equipment to federal agencies, Fisher Scientific has demonstrated considerable capability in delivering specialized testing solutions across multiple government departments and agencies. The AFFIRM VPIII Test Kits procured under this delivery order support the agency's medical supply and testing requirements. Fisher Scientific's extensive track record as a critical federal vendor—with SAM.gov registration dating to July 2001 and major contract relationships with agencies including the National Institutes of Health, Department of Veterans Affairs, and the Food and Drug Administration—positions the company to reliably fulfill this procurement. The company currently holds a significant $1.65 million blanket purchase agreement with the Department of Veterans Affairs for toxicology and drugs of abuse reagents and supplies, further demonstrating its established role in supporting federal healthcare and laboratory testing initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/5/25 |